Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2025-12-24 @ 11:47 PM
NCT ID:
NCT02063451
Eligibility Criteria:
Inclusion Criteria:
* Obese population defined as BMI \> 30 kg/m2.
* Lean population BMI \< 28 but \> 17 kg/m2.
* Able and willing to provide written informed consent for the trial.
* Right handed
* age \>/= 18 years
Exclusion Criteria:
* Evidence of inherited disorders of lipid metabolism.
* History of Cancer within the last 5 years except for minor skin cancers
* Human immunodeficiency virus (HIV) antibody positive.
* Patients with solid organ transplants.
* Positive pregnancy screen in Women
* Uncontrolled thyroid disease
* Unstable angina or NY heart association class II failure or above
* Gastrointestinal disease specifically GI motility disorders
* Unstable neuropsychiatric disease including major depression/anxiety, eating disorder such as bulimia or anorexia
* End stage renal or hepatic disease
* Autoimmune disorders (e.g. SLE)
* Body weight fluctuation of more than 5 kg in the previous 3 months
* Prior bariatric surgery
* A history or current alcohol/substance abuse, or opoid abuse/use and change in smoking habits or cessation in the past 6 months.
* Any medical condition, which in the opinion of the investigator would make the patient unsuitable for recruitment, or could interfere with the patient participating in or completing the protocol.
* Unwilling or unable to consent for the study.
* \> 300 lbs (gantry table limit).
* having a waist diameter \<53 cm (due to fMRI bore diameter)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02063451
Study Brief:
Protocol Section:
NCT02063451